)
)
)
NF2 Therapeutics
NF2 Therapeutics (NF2Tx) is a Cambridge based biotechnology company developing an antibody drug conjugate (ADC) for meningiomas in NF2, and sporadic meningiomas. (NF2 Therapeutics will NOT be meeting any CRO/CDMOs, and other service providers at JPM this year.)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)